Free to Breathe is a partnership of lung cancer survivors, advocates, researchers, healthcare professionals and industry leaders united in the belief that every person with lung cancer deserves a cure. Free to Breathe is dedicated to doubling lung cancer survival by 2022.  To achieve this transformative vision, Free to Breathe is funding research that has the greatest potential to save lives, helping patients understand their treatment options, ensuring that molecular tumor testing is standard of care and working to double the number of lung cancer patients participating in clinical trials.